Background:Venous thromboembolic disease (VTE) is a clinical entity whose two clinical manifestations are deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a frequent and severe disease in Cameroon, thus constituting a significant public health problem.We aimed to describe VTE management in the Yaoundé Emergency Center, in particular the use of thrombolysis. Methods: This was a retrospective study on patients hospitalized at the Yaoundé Emergency Center for DVT and/or PE from January 1, 2015, to December 31, 2020. We collected clinical signs, paraclinical signs, risk factors of VTE, and management methods from each patient. Results: We recruited 106 participants. Dyspneawas the most frequent symptom; PE was the most common form of VTE in eight patients on 10. Obesity and high blood pressure were the main cardiovascular risk factors. The main clinical signs were oedema and pain in the limb for DVT, dyspnea, and tachycardia for PE. Heparinotherapy was the most commonly used management modality. Thrombolysis was performed in 7.5% of participants, especially in the case of hypotension or massive PE. Conclusion: In VTE management, thrombolysis remains the least used therapeutic modality in our context. Heparinotherapy remains the basis of the therapy.
References
[1]
OMS. à propos des maladies cardiovasculaires. WHO.
https://www.who.int/fr/health-topics/cardiovascular-diseases#tab=tab_1
[2]
WHO (2021) Cardiovascular Diseases (CVDs)
http://www.who.int/mediacenter/factsheets/fs317/en/
[3]
Mensah, G.A., Roth, G.A., Sampson, U.K.A., Moran, A.E., Feigin, V.L., Forouzanfar, M.H., et al. (2015) Mortality from Cardiovascular Diseases in Sub-Saharan Africa, 1990-2013: A Systematic Analysis of Data from the Global Burden of Disease Study 2013. Cardiovascular Journal of South Africa, 26, S6-S10.
https://doi.org/10.5830/CVJA-2015-036
[4]
Raskob, G.E., Angchaisuksiri, P., et al. (2014) ISTH Steering Committee for World Thrombosis Day. Thrombosis: A Major Contributor to the Global Disease Burden. Journal of Thrombosis and Haemostasis, 12, 1580-1590.
https://doi.org/10.1111/jth.12698
[5]
Delluc, A., Le Ven, F., Mottier, D. and Le Gal, G. (2012) épidémiologie et facteurs de risque de la maladie veineuse thromboembolique. Revue des Maladies Respiratoires, 29, 254-266. https://doi.org/10.1016/j.rmr.2011.12.001
[6]
Walbane, M. (2015) La maladie thromboembolique veineuse en hospitalisation dans le service de cardiologie du CHU Gabriel TOURE.
https://www.bibliosante.ml/handle/123456789/1005
[7]
Etoundi, P.O., Esiéne, A., Bengono, R.B., Amengle, L., Ela, A.A. and Minkande, J.Z. (2015) La maladie thromboembolique veineuse. Aspects épidémiologiques et facteurs de risque dans un hopital camerounais. Health Sciences and Disease, 16, 1-4. http://www.hsd-fmsb.org/index.php/hsd/article/view/562
[8]
Heit, J.A. (2015) Epidemiology of Venous Thromboembolism. Nature Reviews Cardiology, 12, 464-474. https://doi.org/10.1038/nrcardio.2015.83
[9]
Danwang, C., Temgoua, M.N., Agbor, V.N., Tankeu, A.T., Noubiap, J.J. (2017) Epidemiology of Venous Thromboembolism in Africa: A Systematic Review. Journal of Thrombosis and Haemostasis, 15, 1770-1781. https://doi.org/10.1111/jth.13769
[10]
Ngahane, B.H.M., Kamdem, F., Njonnou, S.R.S., Chebou, N., Dzudie, A., Ebongue, S.A., et al. (2019) Epidemiology, Clinical and Paraclinical Presentations of Pulmonary Embolism: A Cross-Sectional Study in a Sub-Saharan Africa Setting. Open Journal of Respiratory Diseases, 9, 89-99.
https://doi.org/10.4236/ojrd.2019.93008
[11]
Line, B.R. (2001) Pathophysiology and diagnosis of deep venous thrombosis. Seminars in Nuclear Medicine, 31, 90-101. https://doi.org/10.1053/snuc.2001.21406
[12]
Coulibaly, S., Menta, I., Diall, I.B., Ba, H.O., Diakité, M., Sidibé, S., et al. (2018) Maladie Thromboembolique Veineuse dans le Service de Cardiologie du CHU du Point G à Bamako. Health Sciences and Disease, 19, 27-30.
[13]
Dabbouseh, N.M., Patel, J.J. and Bergl, P.A. (2019) Role of Echocardiography in Managing Acute Pulmonary Embolism. Heart (British Cardiac Society), 105, 1785-1792. https://doi.org/10.1136/heartjnl-2019-314776
[14]
Simeni Njonnou, S.R., Nganou Gnindjio, C.N., Ba, H., Boombhi, J., Ahmadou Musa, J., Kuate, M.L., et al. (2019) épidémiologie de le maladie veineuse thromboembolique à Yaoundé: étude transversale en Afrique subsaharienne. La Revue de Médecine Interne, 40, A186. https://doi.org/10.1016/j.revmed.2019.03.254
[15]
Isma, N., Svensson, P.J., Gottsater, A. and Lindblad, B. (2010) Upper Extremity Deep Venous Thrombosis in the Population-Based Malmo Thrombophilia Study (MATS). Epidemiology, Risk Factors, Recurrence Risk, and Mortality. Thrombosis Research, 125, e335-e338. https://doi.org/10.1016/j.thromres.2010.03.005
[16]
Mustafa, J., Asher, I. and Sthoeger, Z. (2018) Upper Extremity Deep Vein Thrombosis: Symptoms, Diagnosis, and Treatment. The Israel Medical Association Journal (IMAJ), 20, 53-57.
[17]
Baatiema, L., Chan, C.K.Y., Sav, A. and Somerset, S. (2017) Interventions for Acute Stroke Management in Africa: A Systematic Review of the Evidence. Systematic Reviews, 6, Article No.213. https://doi.org/10.1186/s13643-017-0594-4
[18]
Ghandehari, K. (2011) Barriers of Thrombolysis Therapy in Developing Countries. Stroke Research and Treatment, 2011, Article ID: 686797.
https://doi.org/10.4061/2011/686797
[19]
Soya, E., N’dJessan, J.J., Traore, F., Bamba, K., Kouame, S., Lawson, N., et al. (2019) Aspects epidemio-clinique et therapeutique de la maladie veineuse thromboembolique A l’Institut de Cardiologie d’Abidjan. Journal de la recherche scientifique de l’Université de Lomé, 21, 203-211.
[20]
Semakula, J.R., Kisa, G., Mouton, J.P., Cohen, K., Blockman, M., Pirmohamed, M., et al. (2021) Anticoagulation in Sub-Saharan Africa: Are Direct Oral Anticoagulants the Answer? A Review of Lessons Learnt from Warfarin. British Journal of Clinical Pharmacology, 87, 3699-3705. https://doi.org/10.1111/bcp.14796
[21]
Pessinaba, S., Atti, Y.D.M., Baragou, S., Yayehd, K., Pio, M., Afassinou, Y.M., et al. (2019) La thrombolyse dans l’embolie pulmonaire à haut risque de mortalité: Expérience d’un service de cardiologie d’Afrique Subsaharienne. Annales de Cardiologie et d’Angéiologie, 68, 28-31. https://doi.org/10.1016/j.ancard.2018.08.026
[22]
Ucar, E.Y. (2019) Update on Thrombolytic Therapy in Acute Pulmonary Thromboembolism. The Eurasian Journal of Medicine, 51, 186-190.
https://doi.org/10.5152/eurasianjmed.2019.19291
